Gaslightwala Abizer bought AKTX

September 29, 2026 · Form 4 insider transaction

Gaslightwala Abizer bought 6,430 shares of Akari Therapeutics, Plc at $9.72 per share, a transaction worth $62.5K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
6,430
Price
$9.72
Total value
$62.5K
RoleDirector
SecurityAmerican Depositary Shares representing Ordinary Shares
Transaction codeA: Grant or award
Transaction dateSeptember 29, 2026
Filing dateOctober 1, 2026
Shares owned after14,107
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

These American Depositary Shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. RSUs were granted on September 29, 2026 and vest in four approximately equal quarterly installments on November 18, 2026, February 18, 2027, May 18, 2027, and August 18, 2027, subject to continued service. The RSUs are subject to forfeiture and cancellation if the Issuer's shareholders do not approve an amendment to the Issuer's equity incentive plan increasing the number of shares reserved for issuance under the plan.

View the original Form 4 on SEC EDGAR